Spironolactone and Tymlos drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Spironolactone (spironolactone) and Tymlos (abaloparatide). Common drug interactions include fatigue among females.
The phase IV clinical study analyzes what interactions people have when they take Spironolactone and Tymlos. It is created by eHealthMe based on reports of 68 people who take the same drugs from the FDA, and is updated regularly.
What is Spironolactone?
Spironolactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 122,947 Spironolactone users. Check the latest studies of Spironolactone.
What is Tymlos?
Tymlos has active ingredients of abaloparatide. eHealthMe is studying from 16,516 Tymlos users. Check the latest studies of Tymlos.
68 people who take Spironolactone and Tymlos together, and have interactions are studied.
What are the common drug interactions of Spironolactone and Tymlos, by gender? *:
female:
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Back pain
- Injection site erythema (redness at injection site)
- Arthralgia (joint pain)
- Heart rate increased
- Renal impairment (severely reduced kidney function)
- Abdominal pain
- Injection site bruising
- Abdominal discomfort
male:
n/a
What are the common drug interactions of Spironolactone and Tymlos, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Alopecia (absence of hair from areas of the body)
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Apathy
- Arthralgia (joint pain)
- Asthenia (weakness)
- Blood thyroid stimulating hormone increased
- Bone pain
- Decreased appetite
- Depressed mood
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Heart rate increased
60+:
- Headache (pain in head)
- Fall
- Renal impairment (severely reduced kidney function)
- Abdominal pain
- Arthralgia (joint pain)
- Bone pain
- Back pain
- Eye irritation
- Flushing (the warm, red condition of human skin)
- Hand fracture
What are the existing conditions these people have? *
- Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 26 people, 38.24%
- Osteoporosis (bones weak and more likely to break): 20 people, 29.41%
- Senile Osteoporosis (weak bones with ageing): 18 people, 26.47%
- Osteoporotic Fracture (fracture due to weak bone): 6 people, 8.82%
* Approximation only. Some reports may have incomplete information.
Do you take Spironolactone and Tymlos?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Spironolactone (122,947 reports)
- Tymlos (16,516 reports)
Browse all drug interactions of Spironolactone and Tymlos:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Spironolactone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Tymlos:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Spironolactone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tymlos and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on spironolactone and abaloparatide (the active ingredients of Spironolactone and Tymlos, respectively), and Spironolactone and Tymlos (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Macrobid and Azathioprine - a second ago
- Could Omega-3-Acid Ethyl Esters cause Renal Failure Aggravated? - 3 seconds ago
- Could Calcium Carbonate cause Toothaches? - 12 seconds ago
- Could Hydrocodone cause Tooth Abscess? - 20 seconds ago
- Could Avastin cause Myasthenia Gravis? - 27 seconds ago
- Could Miralax cause Hypothyroidism? - 27 seconds ago
- Drug interactions of Seebri and Neupogen - 35 seconds ago
- Drug interactions of Axiron and Multivitamin - 35 seconds ago
- Drug interactions of Effexor and Tacrolimus - 38 seconds ago
- Drug interactions of Fluoxetine and Triumeq - 43 seconds ago